Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress

01/07

Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.

Eli Lilly has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.

A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.'s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.'s competing platform, final prices are even lower after the application of promotional coupons.

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1146401006"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146401006\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146401006?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-07 23:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146401006","market":"us","top_or_hot":-1,"title":"Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%","media":"Tiger Newspress","content":"<html><head></head><body><p>Weight-loss drugmakers&#39; stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/68bb1b65fadad1a3b7a308ecfe18a35e\" title=\"\" tg-width=\"534\" tg-height=\"453\"/></p><p><strong><a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></strong> has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.</p><p>A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.&#39;s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.&#39;s competing platform, final prices are even lower after the application of promotional coupons.</p><p>Danish drugmaker <strong><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a></strong> is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2026-01-07 23:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><head></head><body><p>Weight-loss drugmakers&#39; stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/68bb1b65fadad1a3b7a308ecfe18a35e\" title=\"\" tg-width=\"534\" tg-height=\"453\"/></p><p><strong><a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></strong> has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.</p><p>A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.&#39;s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.&#39;s competing platform, final prices are even lower after the application of promotional coupons.</p><p>Danish drugmaker <strong><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a></strong> is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"諾和諾德","start_time":0,"source_url":"","article_id":"1146401006","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146401006","pubTimestamp":1767798955,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","PFE":"辉瑞","VKTX":"Viking Therapeutics, Inc.","LLY":"礼来","GPCR":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","AMGN":"安进","RHHBY":"罗氏控股"},"translate_title":"减肥制药商的股价上涨。Structure Therapeutics上涨5%；礼来涨4%创历史新高；安进上涨3%；罗氏、Novo上涨约2%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHHBY":2,"NVO":2,"PFE":2,"LLY":2,"GPCR":2,"VKTX":2,"AMGN":2},"content_text":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.Eli Lilly has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.'s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.'s competing platform, final prices are even lower after the application of promotional coupons.Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}